Search

Search Results

• Epstein-Barr Virus in Patients with Classical Hodgkin’s Lymphoma

  Vladimir Eduardovich Gurtsevitch, E.A. Demina, N.B. Senyuta, I.V. Botezatu, K.V. Smirnova, T.E. Dushen’kina, D.M. Maksimovich, U.V. Paramonova, I.S. Monin, A.V. Lichtenshtein

  160-166

  01.04.2018

• Polymerase Chain Reaction for Prognosis Assessment and Monitoring of the Epstein-Barr Virus-Associated Hodgkin’s Lymphoma

  M.A. Katin, Ivan Viktorovich Zhil’tsov, V.M. Semenov, D.K. Novik

  182-186

  01.04.2018

• The Use of Brentuximab Vedotin in Relapsed/Refractory Hodgkin’s Lymphoma in the Kransnodar Region

  Ol’ga Dmitrievna Serdyuk, D.A. Yaskul’skii

  50-53

  01.01.2018

• Conventional and Conformal Radiotherapy with and without Beam Intensity Modulation in Patients with Stage II Hodgkin’s Lymphoma with Supradiaphragmal Lesions

  Yu.N. Vinogradova, E.I. Ivanova, A.I. Chumachenko, E.V. Smirnova, G.I. Andreev, A.M. Kalesnik, N.A. Vorob’ev, N.V. Il’in

  70-77

  01.01.2018

• Current Opportunities for Treatment Optimization of Mycosis Fungoides and Sezary Syndrome

  Natal’ya Gennad’evna Chernova, O.A. Kolomeitsev

  34-41

  01.01.2018

• Clinical Significance of the PRAME Gene Expression in Oncohematological Diseases

  Vsevolod Andreevich Misyurin

  26-33

  01.01.2018

• The Comparison of De Novo Grade 3 Follicular Lymphoma and Transformed Grade 3 Follicular Lymphoma: Own Data

  Lyubov’ Vasil’evna Plastinina, A.M. Kovrigina, T.N. Obukhova, E.S. Nesterova, A.U. Magomedova, Ya.K. Mangasarova, A.E. Misyurina, F.E. Babaeva, S.M. Kulikov, A.I. Vorob’ev, S.K. Kravchenko

  453-463

  01.10.2017

• First-Line Therapy for Patients with Advanced Hodgkin’s Lymphoma: Efficacy and Toxicity of Intensive ЕАСОРР-14 Program (NN Blokhin National Medical Cancer Research Center Data)

  Elena Andreevna Demina, A.A. Leont’eva, G.S. Tumyan, Yu.E. Ryabukhina, O.P. Trofimova, N.V. Volkova, Yu.I. Pryamikova, V.M. Sotnikov, V.B. Larionova, E.G. Medvedovskaya, E.V. Paramonova, L.V. Manzyuk, N.A. Probatova, N.V. Kokosadze, E.A. Osmanov

  443-452

  01.10.2017

• Classification of Conditioning Regimens for Bone Marrow Transplantation: Historical Background and Current Perspectives

  Kapitolina Nikolaevna Melkova, G.D. Petrova, N.V. Gorbunova, T.Z. Chernyavskaya, O.P. Trofimova

  494-500

  01.10.2017

• The IVDG Regimen is the Possible Treatment of Choice as First Line Therapy For Hodgkin’s Lymphoma in Elderly Patients with Cardiovascular and Pulmonary Comorbidity

  Kamil’ Daniyalovich Kaplanov, T.Yu. Klitochenko, A.L. Shipaeva, M.N. Shirokova, I.V. Matveeva, N.B. Lavrishina

  358-365

  01.07.2017

• Treatment of Drug-Resistant Mycosis Fungoides and Sezary Syndrome

  Liliya Gamilevna Gorenkova, E.A. Penskaya, S.K. Kravchenko, A.M. Kovrigina, T.N. Moiseeva, A.I. Vorob’ev

  366-371

  01.07.2017

• Role of Superficial CD200 Marker in Differential Diagnosis of Malignant B-Cell Lymphoproliferative Diseases

  Yuliya Vladimirovna Mirolyubova, E.A. Stadnik, T.S. Nikulina, V.V. Strugov, T.O. Andreeva, Yu.V. Virts, R.V. Grozov, A.Yu. Zaritskey

  169-175

  01.04.2017

• Loss of CD20 Expression in Follicular Lymphoma after Program Anti-Tumor Therapy Including Rituximab: Literature Data and Case Report

  Ol’ga Mikhailovna Volodina, N.A. Kupryshina, N.A. Falaleeva, V.A. Doronin, A.V. Mozhenkova, M.A. Frenkel’, E.N. Sorokin, N.V. Kokosadze, N.N. Tupitsyn, G.S. Tumyan, E.A. Osmanov

  176-181

  01.04.2017

• Prognostic and Differential Diagnostic Value of Standardized Uptake Volume (SUV) of Fluorodeoxyglucose in Patients with Hodgkin’s Lymphoma

  Anatolii Anatol’evich Rukavitsyn, S.I. Kurbanov, O.A. Rukavitsyn

  182-186

  01.04.2017

• Relevance of Positron-Emission Therapy for Optimization of Treatment of Advanced Hodgkin’s Lymphoma Using Intensive ЕАСОРР-14 Program

  Elena Andreevna Demina, A.A. Leont’eva, G.S. Tumyan, Yu.E. Ryabukhina, E.G. Medvedovskaya, O.P. Trofimova, V.M. Sotnikov, V.B. Larionova, E.V. Paramonova, L.V. Manzyuk, N.V. Kokosadze, O.V. Mukhortova, I.P. Aslanidi, A.Yu. Zaitseva, L.A. Radkevich, M.S. Rudas, V.A. Manukova, E.A. Osmanov

  150-157

  01.04.2017

• Effect of Patients’ Endocrine Status on Effectiveness of Treatment with Rituximab: State of the Art

  Yuliya Valer’evna Komoza, V.A. Komoza, S.V. Chernavskii, O.A. Rukavitsyn

  187-190

  01.04.2017

• Primary Mediastinal (Thymic) Large B-Cell Lymphoma

  Gayane Sergeevna Tumyan, I.Z. Zavodnova, M.Yu. Kichigina, E.G. Medvedovskaya

  13-24

  01.01.2017

• Diagnosis of Pediatric-Type Follicular Lymphoma in Young Adults (Own Data)

  Alla Mikhailovna Kovrigina, L.V. Plastinina, S.K. Kravchenko, E.S. Nesterova, T.N. Obukhova

  52-60

  01.01.2017

• Features of Imaging of Different Types of Hodgkin’s Lymphoma Using Combined Positron Emission and Computed Tomography

  Aleksei Sergeevich Subbotin, N.G. Afanas’eva

  61-64

  01.01.2017

• Stevens-Johnson Syndrome after Treatment of Female Patient with Small Lymphocytic B-Cell Lymphoma, Autoimmune Hemolytic Anemia and Antiphospholipid Antibody Syndrome with Rituximab

  A.L. Melikyan, Irina Nikolaevna Subortseva, A.M. Kovrigina, T.I. Kolosheinova, E.K. Egorova, E.I. Pustovaya

  120-127

  01.01.2017

• Diagnostic and Prognostic Value of Biochemical Markers of Infectious Complications of High-Dose Therapy with Autologous Hematopoietic Stem Cell Transplantation in Malignant Lymphoproliferative Diseases

  Vladislav Olegovich Sarzhevskii, Yu.N. Dubinina, V.Ya. Mel’nichenko

  113-119

  01.01.2017

• Role of Positron-Emission Tomography in Prognosis of Outcomes of High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Hodgkin’s Lymphoma

  Vsevolod Gennad’evich Potapenko, N.B. Mikhailova, B.I. Smirnov, I.A. Skorokhod, D.A. Chaginskaya, V.V. Ryabchikova, I.A. Samorodova, E.I. Podol’tseva, V.V. Ipatov, I.V. Boikov, V.N. Semelev, D.A. Gornostaev, T.G. Potapenko, T.G. Kulibaba, N.V. Medvedeva, B.V. Afanas’ev

  406-412

  01.10.2016

• Non-Hodgkin’s Lymphomas in Children: 25-Year Clinical Experience

  Timur Teimurazovich Valiev, A.V. Popa, A.S. Levashov, E.S. Belyaeva, N.S. Kulichkina, B.V. Kurdyukov, R.S. Ravshanova, G.L. Mentkevich

  420-437

  01.10.2016

• Brentuximab Vedotin: New Possibilities for Treatment of Relapses and Refractory Hodgkin’s Lymphomas

  Elena Andreevna Demina

  398-405

  01.10.2016

• Biochemical Markers of Cardiotoxicity of High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with Malignant Lymphoproliferative Disorders

  Vladislav Olegovich Sarzhevskii, D.S. Kolesnikova, V.Ya. Mel’nichenko

  465-473

  01.10.2016

• Application of Modern Genome Technologies in Treatment of Lymphomas

  Marina Vyacheslavovna Nemtsova, M.V. Maiorova

  265-270

  01.07.2016

• Pathomorphological Diagnosis of Splenic Diffuse Red Pulp Small B-Cell Lymphoma

  Alla Mikhailovna Kovrigina, S.M. Korzhova, L.S. Al’-Radi, U.L. Dzhulakyan, B.V. Biderman, I.A. Yakutik, A.B. Sudarikov

  287-295

  01.07.2016

• Epstein-Barr Virus and Classical Hodgkin’s Lymphoma

  Vladimir Eduardovich Gurtsevich

  101-114

  01.04.2016

• Modern Aspects of Diagnosis and Treatment of Anaplastic Large Cell Lymphoma in Children (Literature Review)

  Andrei Sergeevich Levashov, T.T. Valiev, A.M. Kovrigina, A.V. Popa, G.L. Mentkevich

  199-207

  01.04.2016

• NK-Cell Lymphoblastic Leukemia/Lymphoma (Literature Review and Authors’ Experience)

  M.A. Frenkel’, O.Yu. Baranova, Alina Sergeevna Antipova, N.A. Kupryshina, N.N. Tupitsyn

  208-217

  01.04.2016

• Resolution of the expert committee on the treatment of refractory forms of follicular lymphoma

  231-232

  01.04.2016

• Treatment of Relapsed and Refractory Hodgkin’s Lymphoma in Children

  N.S. Kulichkina, E.S. Belyaeva, G.L. Mentkevich, V.K. Boyarshinov, A.S. Levashov, I.V. Glekov, Aleksandr Valentinovich Popa

  13-21

  01.01.2016

• Prognostic Significance of Thymidine Kinase-1 versus β2-Microglobulin and Lactate Dehydrogenase in Lymphoproliferative Diseases

  Natal’ya Konstantinovna Parilova, N.S. Sergeeva, N.V. Marshutina, N.G. Tyurina, I.S. Meisner

  6-12

  01.01.2016

• Video-Assisted Thoracoscopic Surgery in Diagnosing Lymphomas

  Igor’ Gennad’evich Komarov, S.Yu. Sletina, M.I. Komarov, А.А. Sukhov

  30-41

  01.01.2016

• Materials of the 13th International Conference on Malignant Lymphoma (June, 2015; Lugano)

  455-462

  01.10.2015

• Treatment of Advanced Stage Hodgkin’s Lymphoma: Literature Review

  Anna Aleksandrovna Leont’eva, E.A. Demina

  255-266

  01.07.2015

• Efficacy and Toxicity of Therapy for Patients with Intermediate-Risk Hodgkin’s Lymphoma: Results of Multicenter Randomized Study

  I.A. Kryachok, Alim Anvarovich Amdiev, I.B. Titorenko, E.M. Aleksik, E.O. Ul’yanchenko, O.I. Novosad, E.S. Filonenko, M.I. Kasich, M.Ya. Kiseleva

  281-286

  01.07.2015

• Autologous Stem Cell Transplantation in Primary Refractory Hodgkin’s Lymphoma: Supposed Zugzwang or Zwischenzug?

  Galina Dmitrievna Petrova, K.N. Melkova, T.Z. Chernyavskaya, N.V. Gorbunova, B.V. Afanas’ev, E.A. Demina, V.N. Kostrykina, V.A. Doronin

  321-330

  01.07.2015

• Modern Aspects of Diagnosis and Treatment of Complicated Forms of Non-Hodgkin’s Lymphomas of Small and Large Intestine

  Ol’ga Aleksandrovna Malikhova, A.O. Tumanyan, V.A. Shalenkov, A.G. Malikhov, Yu.P. Kuvshinov, G.V. Ungiadze

  129-135

  01.04.2015

• Secondary Hemophagocytic Syndrome in the Adult Patients. Literature Review and Authors’ Experience

  Vsevolod Gennad’evich Potapenko, N.A. Potikhonova, V.V. Baikov, M.B. Belogurova, I.A. Lisukov, A.V. Klimovich, S.V. Lapin, M.O. Ivanova, V.M. Kravtsova, E.I. Podol’tseva, N.V. Medvedeva, B.V. Afanas’ev

  169-184

  01.04.2015